Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GENTAERO: Inhaled vs Parenteral Gentamicin in VAP
NCT02515448Phase 1Completed
- Sponsor
- CHU de Poitiers
- Start
- Oct 2015
- Primary completion
- Nov 2016
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of gentamicin in ventilator-associated pneumonia (VAP), sponsored by CHU de Poitiers. Primary endpoint: Peak Plasma Concentration at 3 days. Started Oct 2015; status: completed.
02
Drugs
gentamicin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT02515448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02515448.